This content is restricted.
Brief
Summary:
The given document provides a list of recent changes to the Manual of Patent Practice. These changes are categorized by month, from January 2021 to October 2023. The summary highlights the main updates made to specific paragraphs and sections of the manual.
Key updates:
October 2023 changes: Updates to paragraphs 20.02, 36.07, and 15.20.1 in light of recent court decisions and practice changes.
January 2023 changes: Updates to paragraph 20.02 in light of Xu's Application and changes to paragraphs 125.17.8 and 125.18.8 in light of Vernacare Ltd v Moulded Fibre Products.
October 2022 changes: Updates to paragraphs 2.08.1, S.13, S.89B, and SPM 3.03.1 in light of Zebra Technologies Corporation, Thaler's Application, and Roche Glycart AG.
July 2022 changes: Updates to paragraphs 4A.29.4.1, 67.04, and SPM 1.04.2 in light of Sandoz Ltd v Teva Pharmaceutical Industries Ltd and Neurim Pharmaceuticals v Generics (UK) Ltd.
* April 2022 changes: Updates to paragraphs 3.87.2, S.17, S.18, and SPM 8.10.1 in light of Teva Pharmaceutical Industries Ltd & Ors v Bayer Healthcare LLC and Chiesi Farmaceutici S.P.A.
Overall, the changes aim to reflect recent court decisions and updates to patent practice.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
